Healthcare - Medical - Devices - NASDAQ - US
$ 1.04
-3.7 %
$ 44.8 M
Market Cap
-1.01
P/E
CASH FLOW STATEMENT
-45.1 M
OPERATING CASH FLOW
42.2 M
INVESTING CASH FLOW
149 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Rapid Micro Biosystems, Inc.
| Net Income | -52.5 M |
| Depreciation & Amortization | 3.1 M |
| Capital Expenditures | -1.84 M |
| Stock-Based Compensation | 4.75 M |
| Change in Working Capital | 555 K |
| Others | 1.96 M |
| Free Cash Flow | -46.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (52.5) | (60.8) | (73.5) | (37.1) | (21.2) |
| Depreciation & Amortization | 3.1 | 2.8 | 1.5 | 1.5 | 1.5 |
| Deferred Income Tax | 0 | 0 | 22.8 | 3.1 | (0.2) |
| Stock Based Compensation | 4.8 | 4.0 | 1.8 | 0.5 | 0.5 |
| Other Operating Activities | (1.0) | 0.7 | 0.4 | 2.0 | 0.4 |
| Change in Working Capital | 0.6 | (5.3) | (8.0) | (1.1) | (2.1) |
| Cash From Operations | (45.1) | (58.5) | (55.0) | (31.0) | (21.1) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (1.8) | (6.7) | (3.2) | (0.7) | (1.7) |
| Other Items | 44.0 | (86.7) | (10.1) | (15.0) | 0 |
| Cash From Investing Activities | 42.2 | (93.5) | (13.3) | (15.7) | (1.7) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0.2 | 0.2 | 0 | 0 | 0 |
| Total Debt Repaid | 37 K | 33 K | (26.2) | 16.5 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.2 | 0.7 | 78.8 | 47.7 | 14.9 |
| Cash From Financing Activities | 0.1 | 0.7 | 216.7 | 64.2 | 14.9 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (2.8) | (151.3) | 148.5 | 17.6 | (8.0) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (46.9) | (65.3) | (58.2) | (31.7) | (22.8) |